Trials / Completed
CompletedNCT04289662
K-924 Phase III Long Term Study
A Multicenter, Open-label Study to Evaluate 52 Weeks Long Term Efficacy and Safety of K-924 in Patients With Hypercholesterolemia Who Were Treated With Pitavastatin 2 mg or 4 mg.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Kowa Company, Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Open-label Study to Evaluate 52 weeks long term Efficacy and Safety of K-924 in Patients with hypercholesterolemia who were treated with pitavastatin 2 mg or 4 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-924 LD | Pitavastatin 2 mg / Ezetimibe 10 mg tables |
| DRUG | K-924 HD | Pitavastatin 4 mg / Ezetimibe 10 mg tables |
Timeline
- Start date
- 2020-03-23
- Primary completion
- 2021-08-07
- Completion
- 2021-08-07
- First posted
- 2020-02-28
- Last updated
- 2023-11-29
Locations
13 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT04289662. Inclusion in this directory is not an endorsement.